MEF2D and Parkinson disease: It was observed that MEF2D can be degraded by CMA and, therefore, its levels were increased in a transgenic mouse model overexpressing α-syn, similar to samples derived from PD brains, thus indicating a direct connection between CMA regulation and neuronal survival [122].